Skip to content
Review Open access

The Inter-relationship between Sarcopenia and Osteoporosis : Molecular Mechanisms and Therapeutic Interventions.

Sep 2026 · Journal of Korean Neurosurgical Society · 0 citations · 23 references
Medicine

TL;DR

This narrative review synthesizes current evidence supporting osteosarcopenia as an integrated musculoskeletal syndrome, with a particular focus on biomechanical loading, biochemical crosstalk, and inflammatory signaling.

Abstract

Sarcopenia and osteoporosis are prevalent age-related musculoskeletal disorders that frequently coexist and interact, giving rise to the clinical entity known as osteosarcopenia. Although traditionally considered distinct entities, growing evidence indicates that muscle and bone are functionally integrated through biomechanical and biochemical crosstalk. Sarcopenia is characterized by progressive loss of skeletal muscle mass, strength, and function, whereas osteoporosis is defined by reduced bone mineral density (BMD) and microarchitectural deterioration, resulting in increased fracture risk. Both conditions share common risk factors, including aging, chronic inflammation, hormonal changes, physical inactivity, and nutritional deficiencies. Emerging evidence highlights the important role of muscle-derived myokines, bone-derived osteokines, and adipokines in mediating inter-organ communication within the musculoskeletal unit. This narrative review synthesizes current evidence supporting osteosarcopenia as an integrated musculoskeletal syndrome, with a particular focus on biomechanical loading, biochemical crosstalk, and inflammatory signaling. In addition, we discuss diagnostic challenges and therapeutic strategies, emphasizing integrated assessment and management approaches that target skeletal fragility, muscle dysfunction, and musculoskeletal interfaces to reduce frailty, falls, and fractures in aging populations.

Read PDF

Similar papers

Open access Aug 2026

Osteosarcopenia Revisited: From Mechanisms to Management.

Sarcopenia and osteoporosis are characterized by insufficient mass and function of skeletal muscle and bone, and often co-occur in older persons, a condition called osteosarcopenia. Loss of bone and skeletal muscle mass and function is driven by multiple risk factors that activate the hallmarks of aging. Recent genome-...

Takayoshi Sasako, M. G. Borda, Marc Sim et al. · 0 citations
Review Open access Aug 2026

Shared mechanisms of musculoskeletal dysfunction in type 2 diabetes mellitus: Insights into future therapeutic directions (Review)

Although the manifestations of T2DM differ among skeletal muscle, tendon, TBI and bone, these tissues share common pathological drivers, including metabolic dysregulation, chronic inflammation, oxidative stress, extracellular matrix remodeling, and impaired regenerative capacity.

Zhen-Hong He, Han-Yu Li, Yu-Han Luo et al. · 1 citation
Review Open access Sep 2026

Diabetic Bone Disease and Fracture Healing: Molecular Mechanisms, Skeletal Fragility, and Emerging Orthopedic Therapeutic Strategies

Diabetes mellitus is increasingly recognized as a disorder of skeletal quality in addition to metabolic dysregulation. Both type 1 and type 2 diabetes are associated with increased fracture risk, impaired fracture healing, and higher rates of orthopedic complications despite preserved or even elevated bone mineral dens...

Max Latshaw, Aaron J. Gillespie, Hasan Pracha et al. · 0 citations
Review Open access Sep 2026

Cancer-Associated Osteoporosis and Treatment-Induced Bone Loss: Mechanisms, Prevention, and Therapeutic Strategies

Background. Cancer-associated osteoporosis and cancer treatment-induced bone loss (CTIBL) are important causes of skeletal morbidity. Fracture risk reflects the interaction of treatment-related bone loss, endocrine disruption, and deterioration of the muscle–bone unit and may not be adequately captured by bone mineral...

P. Turzyńska · 0 citations
Review Open access Aug 2026

Transcending aging: disease specificity, assessment challenges, and management strategies for rheumatoid arthritis-related sarcopenia

Rheumatoid arthritis (RA) is a systemic autoimmune disorder marked by chronic synovitis, with pathological damages extending beyond joint destruction to skeletal muscle, bone and metabolic homeostasis. Sarcopenia is conventionally regarded as age-driven degeneration, yet its high prevalence in young RA patients indicat...

Xuchen Ren, Shuang Ren · 0 citations
Open access Aug 2026

Muscle & Bone Health After 40

Osteosarcopenia is now recognised as one of the most clinically significant musculoskeletal conditions of ageing. Both sarcopenia and osteoporosis share common pathophysiological roots: declining levels of anabolic hormones (including oestrogen,- testosterone and insulin-like growth factor-1), rising systemic inflammat...

Dr.Usman Mansoor · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.